Profiel
Phil Wilson formerly worked at Catalent Pharma Solutions, Inc., as Director-Global Operational Programs, Catalent Pharma Solutions, Inc., as Director-Global Operational Programs from 2007 to 2017, CryoPort, Inc., as SVP-Global Operations & Supply Chain, and Ancillare LP, as Vice President-Supply Chain.
Mr. Wilson received his graduate degree from The Pennsylvania State University.
Eerdere bekende functies van Phil Wilson
Bedrijven | Functie | Einde |
---|---|---|
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | 01-06-2017 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | - |
Ancillare LP
Ancillare LP Air Freight/CouriersTransportation Part of JSGP LLC, Ancillare LP is an American company that has been creating and innovating the Clinical Trial Ancillary Supply Chain (CTASC™) since 2006. The private company's focus is on proving that well-planned clinical supply chains can help accelerate approvals of life-saving therapies for patients. | Corporate Officer/Principal | - |
CRYOPORT, INC. | Chief Operating Officer | - |
Opleiding van Phil Wilson
The Pennsylvania State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CRYOPORT, INC. | Transportation |
Bedrijven in privébezit | 2 |
---|---|
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Ancillare LP
Ancillare LP Air Freight/CouriersTransportation Part of JSGP LLC, Ancillare LP is an American company that has been creating and innovating the Clinical Trial Ancillary Supply Chain (CTASC™) since 2006. The private company's focus is on proving that well-planned clinical supply chains can help accelerate approvals of life-saving therapies for patients. | Transportation |